Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
Quoin Pharmaceuticals Ltd
Operating Income
Quoin Pharmaceuticals Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Q
|
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
|
Operating Income
-$9.1m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
Compugen Ltd
NASDAQ:CGEN
|
Operating Income
-$13m
|
CAGR 3-Years
26%
|
CAGR 5-Years
11%
|
CAGR 10-Years
0%
|
|
B
|
Biolight Life Sciences Ltd
TASE:BOLT
|
Operating Income
-₪10.7m
|
CAGR 3-Years
2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
9%
|
See Also
What is Quoin Pharmaceuticals Ltd's Operating Income?
Operating Income
-9.1m
USD
Based on the financial report for Mar 31, 2024, Quoin Pharmaceuticals Ltd's Operating Income amounts to -9.1m USD.
What is Quoin Pharmaceuticals Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
-3%
Over the last year, the Operating Income growth was 8%. The average annual Operating Income growth rates for Quoin Pharmaceuticals Ltd have been -35% over the past three years , -3% over the past five years .